Upcoming talk: Forget everything you thought you knew about biotechnology entrepreneurship
I’ll be at Rutgers on February 29th, giving a talk on biotechnology entrepreneurship. My objective is to dispel the popular […]
I’ll be at Rutgers on February 29th, giving a talk on biotechnology entrepreneurship. My objective is to dispel the popular […]
The following appeal for generic biologic legislation was sent in from Insmed via youtube. I’ve posted previously on the challenges
Two new biotechnology books due out in March 2008: [AMAZONPRODUCT=0973467673] Best Practices in Biotechnology Education 22 International Best Practices in
On returning from a meeting with a small biotechnology firm in which I serve on the advisory board, I was
Want biotechnology venture capital? Use a shotgun! Read Post »
After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just
Journal of Commercial Biotechnology – January 2008 Read Post »
My recent presentation at the “Biotechnology for Turkey” conference has been posted online. My central thesis was that the challenges
Guest content from John Avellanet, managing director of Cerulean Associates: The US Food and Drug Administration (FDA) intends to increase
At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so
I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University
Bio-Rad’s got an interesting website up: RethinkPCR. The company’s name isn’t posted on the front page, but is readily available
Get new actionable insights and updates from BiotechBlog